Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Trulieve Cannabis (TCNNF) Raw Materials (2020 - 2023)

Trulieve Cannabis has reported Raw Materials over the past 4 years, most recently at $59.1 million for Q2 2023.

  • For Q2 2023, Raw Materials fell 29.57% year-over-year to $59.1 million; the TTM value through Jun 2023 reached $59.1 million, down 29.57%, while the annual FY2022 figure was $71.2 million, 0.6% down from the prior year.
  • Raw Materials for Q2 2023 was $59.1 million at Trulieve Cannabis, down from $76.0 million in the prior quarter.
  • Over five years, Raw Materials peaked at $83.9 million in Q2 2022 and troughed at $21.9 million in Q4 2020.
  • A 4-year average of $58.1 million and a median of $71.2 million in 2022 define the central range for Raw Materials.
  • Biggest five-year swings in Raw Materials: skyrocketed 227.05% in 2021 and later decreased 29.57% in 2023.
  • Year by year, Raw Materials stood at $21.9 million in 2020, then skyrocketed by 227.05% to $71.6 million in 2021, then fell by 0.6% to $71.2 million in 2022, then fell by 16.94% to $59.1 million in 2023.
  • Business Quant data shows Raw Materials for TCNNF at $59.1 million in Q2 2023, $76.0 million in Q1 2023, and $71.2 million in Q4 2022.